-
Genetic Testing for Women With Breast CancerNew recommendations clarify when women diagnosed with breast cancer should be offered genetic testing for inherited cancer risk.
by Laura Gesualdi-Gilmore
-
Germline Genetic Testing Lags Behind GuidelinesLow rates of germline genetic testing in cancer patients means information that could affect treatment isn’t available.
by Jon Kelvey
Cancer Talk
Delaying Treatment Resistance
Adding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
2024: The Year in Cancer NewsThe Cancer Today editors share the most impactful reporting on cancer research from 2024.
by Cancer Today staff
Cancer Today Editors’ Picks: 2024Our favorite Cancer Today stories from 2024, as picked by the editors.
Rethinking the Role of RadiationChest radiation may not be necessary for people with intermediate-risk breast cancer.
by Thomas Celona
From the AACR
-
AACR Grant Propels Progress in Immunotherapy ResearchA grant from the American Association for Cancer Research (AACR) helped Marco Ruella, MD, develop a new approach to immunotherapy.
-
Self-screening for Cancer: Home Sweet HomeNew cervical cancer self-screening options and a portable blood test device could lead to changes in at-home cancer screening.
Video
Alexis Browning
